Gleason score / ISUP grade group
Deterministic view of the source YAML entity. Clinical authority remains with the cited source IDs and reviewer sign-off state.
| ID | BIO-GLEASON-ISUP |
|---|---|
| Type | Biomarker |
| Aliases | Бал Глісона / ISUP grade group |
| Status | pending_clinical_signoff |
| Diseases | None declared |
| Sources | None declared |
Biomarker Facts
| Biomarker type | pathology_grading |
|---|---|
| Measurement | MethodHistopathology of biopsy / RP specimen UnitsGleason 6-10 / ISUP 1-5 Typical range
|
| Related biomarkers | None declared |
Notes
Universal pathology-grading framework. WHO 2022 endorses ISUP grade group nomenclature; older Gleason notation still common in clinical reports.
Used By
Indications
IND-PROSTATE-MCRPC-1L-ARPI- IND-PROSTATE-MCRPC-1L-ARPIIND-PROSTATE-MCRPC-1L-PARPI- IND-PROSTATE-MCRPC-1L-PARPIIND-PROSTATE-MCRPC-2L-CABAZITAXEL- IND-PROSTATE-MCRPC-2L-CABAZITAXELIND-PROSTATE-MCRPC-2L-DOCETAXEL- IND-PROSTATE-MCRPC-2L-DOCETAXELIND-PROSTATE-MCRPC-2L-LU-PSMA- IND-PROSTATE-MCRPC-2L-LU-PSMAIND-PROSTATE-MCRPC-2L-PARPI- IND-PROSTATE-MCRPC-2L-PARPIIND-PROSTATE-MCRPC-2L-RADIUM223- IND-PROSTATE-MCRPC-2L-RADIUM223IND-PROSTATE-MHSPC-1L-ARPI-DOUBLET- IND-PROSTATE-MHSPC-1L-ARPI-DOUBLETIND-PROSTATE-MHSPC-1L-TRIPLET- IND-PROSTATE-MHSPC-1L-TRIPLET
Questionnaires
QUEST-PROSTATE-1L-STUB- Prostate adenocarcinoma — first line